STIM
Neuronetics, Inc. · Healthcare
Insiders bought $860K of Neuronetics, Inc. in the last 12 months
1 insider bought on 4 days.
STIM over the last year
Largest buyers, last 12 months
STIM after insider buys
3 months after each buy, from the first price a copier could get.
8 buys since 2018 with 3 months of prices.
Every filing
84 insider filings since 2018, newest first
Jorey Chernett · 10% owner
Jorey Chernett · 10% owner
Jorey Chernett · 10% owner
Jorey Chernett · 10% owner
Keith J Sullivan · Former Officer & Director
Keith J Sullivan · President and CEO
Keith J Sullivan · President and CEO
Robert Cascella · Director
Keith J Sullivan · President and CEO
Keith J Sullivan · President and CEO
Robert Cascella · Director
William Andrew Macan · EVP, GC, CCO, CS
Stephen Furlong · EVP, CFO and Treasurer
Keith J Sullivan · President and CEO
Keith J Sullivan · President and CEO
Keith J Sullivan · President and CEO
William Andrew Macan · EVP, GC, CCO, CS
Stephen Furlong · EVP, CFO and Treasurer
Keith J Sullivan · President and CEO
William Andrew Macan · EVP, GC, CCO, CS
Robert Cascella · Director
Keith J Sullivan · President and CEO
John K Bakewell · Director
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
William Andrew Macan · EVP, GC, CCO, CS
Stephen Furlong · EVP, CFO and Treasurer
William Andrew Macan · EVP, GC, CCO, CS
Stephen Furlong · CFO
Keith J Sullivan · President and CEO
William Andrew Macan · SVP and General Counsel
Stephen Furlong · CFO
William Andrew Macan · SVP and General Counsel
Stephen Furlong · CFO
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Stephen Furlong · CFO
Keith J Sullivan · President and CEO
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Cannell Capital LLC · 10% owner
Stephen Furlong · CFO
About Neuronetics, Inc.
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.